Pioneering Neurological Hope

At PhenoNet, rigorous science meets human hope. Based in North America, we develop pioneering therapies for ALS and Alzheimer's through innovation, transparency, and clinical research

Our Quest

PhenoNet was founded on the conviction that the cure for ALS and Alzheimer’s is within reach. By integrating advanced phenotypic screening with clinical research, we translate complex molecular data into life-changing therapies. Our North American team works tirelessly to bridge the gap between initial discovery and patient care, ensuring every breakthrough serves those who need it most.

Research Lab

Our state-of-the-art North American labs utilize patient-derived cell models to identify critical biomarkers of neurodegeneration. This precision-focused approach allows us to accelerate the drug discovery process, ensuring that promising candidates move through the development pipeline with speed and scientific integrity.

Scientific Focus

We focus on the underlying mechanisms of neuroinflammation and protein misfolding. Our therapeutic strategies aim to protect neurons and restore cellular function. By targeting these foundational causes, we work toward disease-modifying treatments that offer more than just symptomatic relief, but a genuine halt to disease progression.

The Team

Our team is comprised of world-class neuroscientists and clinical experts based in North America. Together, we are committed to unlocking the mysteries of the brain to provide real solutions for patients facing ALS and Alzheimer's disease today.